title: Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation.
authors.affiliation: Heart Research Institute, Charles Perkins Centre, University of Sydney, Sydney, Australia2Sydney Medical School, University of Sydney, Sydney, Australia3Department of Cardiology, Concord Repatriation General Hospital and Anzac Research Institute, Sydney.
authors.forename: Ben
authors.initials: B
authors.lastname: Freedman
authors.affiliation: Institute for Epidemiology, Statistics and Informatics GmbH, Frankfurt, Germany.
authors.forename: Carlos
authors.initials: C
authors.lastname: Martinez
authors.affiliation: Institute for Epidemiology, Statistics and Informatics GmbH, Frankfurt, Germany.
authors.forename: Anja
authors.initials: A
authors.lastname: Katholing
authors.affiliation: Institute for Epidemiology, Statistics and Informatics GmbH, Frankfurt, Germany.
authors.forename: Stephan
authors.initials: S
authors.lastname: Rietbrock
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000150:complications* / Q000401:mortality*; D005260:Female; D006801:Humans; D008297:Male; D020521:Stroke / Q000139:chemically induced*; D014859:Warfarin / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D014859:Warfarin